Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
193.90
+0.50 (+0.26%)
Official Closing Price
Updated: 6:30 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about AbbVie
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
65
66
Next >
Should You Load Up On This 1 Dividend Stock?
October 06, 2023
It's not that hard a call.
Via
The Motley Fool
Retirement Royalty: 3 Dividend Aristocrats for a Steady Income Stream
October 05, 2023
These dividend aristocrats are some of the best options for long-term investors looking to boost their portfolio return.
Via
InvestorPlace
Topics
Retirement
Exposures
Pension
7 Top Healthcare Stocks That Pay Dividends
October 04, 2023
With uncertainty being the dominant theme of the moment, investors should consider healthcare stocks that pay dividends.
Via
InvestorPlace
3 High-Yielding Dividend Growth Stocks That Have Increased Their Payouts by 50% in 5 Years
October 04, 2023
These are relatively safe income investments that you can hold on to for the long haul.
Via
The Motley Fool
Check Out What Whales Are Doing With ABBV
October 03, 2023
Via
Benzinga
3 Top Stocks to Buy in October and Hold Forever
October 02, 2023
Check out these three blue chip buys playing crucial roles in America's $6 trillion healthcare opportunity.
Via
The Motley Fool
What 4 Analyst Ratings Have To Say About AbbVie
September 29, 2023
Via
Benzinga
If You Invested $100 In This Stock 10 Years Ago, You Would Have $300 Today
September 27, 2023
Via
Benzinga
AbbVie Unusual Options Activity
September 26, 2023
Via
Benzinga
These Market Experts See a Downturn Coming: 2 Defensive Index Funds That Are Proven Moneymakers to Buy Now
October 01, 2023
These defensive index funds can help investors hedge against a possible recession.
Via
The Motley Fool
Week In Review: Adlai Nortye Stages $97.5 Million US IPO On Nasdaq
September 30, 2023
While ANL's IPO dropped more than 25% on its first day, netting just under $60M, private placement made up the difference. Plus: Deals, financings, trials and approvals.
Via
Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
Moonshot Medicine: 3 Stocks to Buy to Bet on Long-Shot Drugs
September 30, 2023
The best drug stocks to buy now are shooting for the moon. These three trailblazers will land among the stars.
Via
InvestorPlace
3 Magnificent Dividend Stocks to Buy in October
September 30, 2023
These stocks come with great dividends and more.
Via
The Motley Fool
AbbVie's Promising Leap Towards Long-Term Growth: Analyst
September 29, 2023
Raymond James initiated coverage on AbbVie Inc (NYSE: ABBV) as the company looks beyond Humira's loss of exclusivity and has several levers to set up long-term growth.
Via
Benzinga
How Is The Market Feeling About AbbVie?
September 25, 2023
Via
Benzinga
AbbVie's Leukemia Drug Falls Short In Late-Stage Study In Pretreated Blood Cancer Patients
September 29, 2023
AbbVie Inc (NASDAQ: ABBV) released data from its Phase 3 CANOVA study evaluating venetoclax (Venclexta/ Venclyxto) plus dexamethasone (VenDex) for patients with t(11;14)-positive relapsed or refractory...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 29, 2023
September 29, 2023
Via
Benzinga
Want $500 in Passive Income? Invest $3,500 Into These 3 Dividend Stocks and Wait 4 Years
September 29, 2023
A basket of passive income opportunities in oil and gas, renewable energy, and healthcare.
Via
The Motley Fool
Three Of Our Top Picks For Your Healthcare Portfolio
September 26, 2023
Amidst macro uncertainty, healthcare stocks should outperform.
Via
Talk Markets
Don’t Miss the Boom: 3 Biotech Stocks Set to Explode Higher
September 26, 2023
With their seamless blend of promise and innovation, these biotech stocks to buy offer a strategic gateway to fortify your portfolio.
Via
InvestorPlace
Clorox Pullback Presents a Chance to Clean Up on a 3.6% Dividend
September 26, 2023
The Clorox Company's 44% two-year plunge has created an opportunity to own a defensive stock with a shiny 3.6% dividend.
Via
MarketBeat
Argenx's 28% Surge & Promising Product Propel Investor Confidence
September 25, 2023
Argenx's chart is forming a bullish base after a 28% jump after positive clinical trials. Analysts believe the immunology specialist is an acquisition target.
Via
MarketBeat
3 Bargain Stocks to Buy in a Market That's Priced for Perfection
September 21, 2023
Many stocks have nosebleed valuations. But not these.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
September 21, 2023
Via
Benzinga
Only 7 Large-Cap Dividend Kings Yield Over 3%. Here's My Top Pick to Buy Now.
September 21, 2023
Dividend Kings are passive income powerhouses, but they aren't always a good value.
Via
The Motley Fool
Flee to Healthcare Stocks if Recession Rears its Head?
September 20, 2023
In uncertain economic conditions, healthcare stocks can be a refuge due to steady demand and favorable inflation conditions. Many also offer dividends.
Via
MarketBeat
Topics
Economy
Exposures
Economy
Interest Rates
Former IBD 50 Stock Revance Implodes As Its 'Prestige' Plan Goes Up In Smoke
September 19, 2023
The company is still figuring out how to gain share in a market topped by AbbVie.
Via
Investor's Business Daily
7 Safe and Steady Dividend Stocks to Buy for Volatile Time
September 19, 2023
Discover how these seven standout companies offer both security and growth potential in an uncertain financial landscape.
Via
InvestorPlace
The Breakthrough Therapy Aiming To Solve The World’s Mental Health Crisis
September 19, 2023
EQNX::TICKER_START (NYSE:JNJ),(NYSE:ABBV),(NASDAQ:ATAI),(NASDAQ:CMPS),(NASDAQ:MNMD) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Economy
Exposures
Economy
Product Safety
The Top 7 Underrated Dividend Stocks Yielding 3% or More
September 19, 2023
Investors seeking dependable income and upside should buy these dividend stocks yielding 3% or more, the sooner the better
Via
InvestorPlace
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
65
66
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.